Group 1 - On September 15, a block trade of 358,600 shares of Ailis was executed, with a transaction value of 36.613 million yuan, accounting for 6.44% of the total transaction value for that day [1] - The transaction price was 102.1 yuan, representing a 9% discount compared to the market closing price of 112.2 yuan [1] Group 2 - The block trade involved multiple institutional buyers, with significant participation from CITIC Securities and Huajin Securities [2] - The transaction details indicate a variety of buying departments, all categorized as institutional, highlighting strong institutional interest in Ailis shares [2]

Core Points - The company Ailis (688578.SH) announced a significant change in shareholder equity, with shareholders Shanghai Aixiang and Nantong Aiyun reducing their stakes, triggering a notification due to the change reaching a 1% threshold [1] - The reduction occurred between September 2, 2025, and September 12, 2025, with a total of 4,025,400 shares sold through block trades and centralized bidding [1] - Following the reduction, Shanghai Aixiang holds 25,727,034 shares (5.72% of total equity), while Nantong Aiyun holds 7,632,088 shares (1.70% of total equity) [1] Shareholder Changes - The combined shareholding of Shanghai Aixiang, Nantong Aiyun, and their concerted parties decreased from 51.87% to 50.97% [1] - The weighted average price of Ailis shares during the reduction period was 115.476 yuan, resulting in a total reduction amount of 465 million yuan [2] - The actual controllers of Ailis are Du Jinhao and Qi Jufu, with Du Jinhao serving as the executive partner of both Shanghai Aixiang and Nantong Aiyun [2]

Core Viewpoint - The announcement details a change in shareholder equity for Shanghai Ailis Pharmaceutical Technology Co., Ltd., indicating that certain shareholders have reduced their holdings, resulting in a decrease in their ownership percentage to below a significant threshold [4][5]. Group 1: Shareholder Information - The shareholders involved in the equity change are Shanghai Aixiang Enterprise Development Center (Limited Partnership) and Nantong Aiyun Enterprise Development Center (Limited Partnership), along with their concerted actions [3][4]. - The specific addresses of the shareholders are provided, indicating their locations in Shanghai and Jiangsu [3]. Group 2: Equity Change Details - From September 2 to September 12, 2025, the shareholders reduced their holdings by a total of 4,025,400 shares through block trading and centralized bidding, with Shanghai Aixiang reducing by 2,971,900 shares and Nantong Aiyun by 1,053,500 shares [4]. - Post-reduction, Shanghai Aixiang holds 25,727,034 shares (5.72% of total shares), while Nantong Aiyun holds 7,632,088 shares (1.70% of total shares) [4]. - The combined shareholding of the shareholders and their concerted actions decreased from 51.87% to 50.97%, crossing the 1% threshold [4]. Group 3: Additional Notes - The reduction in shares is part of a previously disclosed plan and does not trigger a mandatory tender offer, nor does it affect the control of the company or its governance structure [5]. - The shareholders have committed to adhering to relevant laws and regulations regarding further disclosures related to their shareholding changes [5].

Summary of Key Points Core Viewpoint - On September 12, 2023, Elys reported significant trading activity on the block trading platform, indicating notable investor interest despite a recent decline in stock price [2]. Trading Activity - A total of 4 block trades occurred on September 12, with a cumulative volume of 285,200 shares and a total transaction value of 29.52 million yuan [2]. - The transaction price was consistently 103.54 yuan, reflecting a discount of 9.00% compared to the closing price of the same day [2]. Recent Performance - Over the past three months, Elys has recorded 71 block trades, amounting to a total transaction value of 874 million yuan [2]. - The closing price on September 12 was 113.78 yuan, which represented a decline of 1.04% for the day [2]. - The stock's turnover rate was 1.33%, with a total trading volume of 682 million yuan and a net outflow of 30.04 million yuan in principal funds for the day [2]. - In the last five days, the stock has decreased by 2.62%, with a total net outflow of 162 million yuan [2]. Margin Trading Data - The latest margin financing balance for Elys is 896 million yuan, which has decreased by 18.63 million yuan over the past five days, reflecting a decline of 2.04% [2].

| 权益变动方向 | 比例增加□ | | 比例减少 | | --- | --- | --- | --- | | 权益变动前合计比例 | 51.87% | | | | 权益变动后合计比例 | 50.97% | | | | 本次变动是否违反已作出的承 | 是□ | 否 | | | 诺、意向、计划 | | | | | 是否触发强制要约收购义务 | 是□ | 否 | | 一、 信息披露义务人及其一致行动人的基本信息 证券代码：688578 证券简称：艾力斯 公告编号：2025-023 上海艾力斯医药科技股份有限公司 关于股东权益变动触及 1%刻度的提示性公告 股东上海艾祥企业发展中心（有限合伙）、南通艾耘企业发展中心（有限合伙）及 其一致行动人杜锦豪、上海乔可企业发展有限公司、JEFFREY YANG GUO 及 JENNIFER GUO 保证向上海艾力斯医药科技股份有限公司提供的信息真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 本公司董事会及全体董事保证公告内容与信息披露义务人提供的信息一致。 重要内容提示： 1.身份类别 投资者及其一致行动人的身份 控股股东/实际控制人及其一致行动人 □其他 5 ...

Group 1 - On September 12, a block trade of 285,200 shares of Ailis was executed, amounting to 29.5296 million yuan, which accounted for 4.15% of the total trading volume for that day [1] - The transaction price was 103.54 yuan, representing a 9% discount compared to the market closing price of 113.78 yuan [1] Group 2 - The block trade involved multiple transactions with different amounts and prices, all at 103.54 yuan [2] - The largest transaction was 1,434.03 million yuan for 13.85 thousand shares, executed by Huajin Securities [2] - Other notable transactions included amounts of 798.29 million yuan for 7.71 thousand shares and 483.53 million yuan for 4.67 thousand shares, also involving Huajin Securities and JPMorgan [2]

Summary of Key Points Core Viewpoint - On September 11, a total of 105 stocks were traded on the block trading platform, with a cumulative trading volume of 217 million shares and a total transaction value of 3.577 billion yuan, indicating active trading in the market [1]. Group 1: Top Block Trades - The highest transaction value was recorded by China Western Electric, with a single transaction amounting to 593 million yuan [1]. - Huatai Medical followed closely with a transaction value of 537 million yuan from one trade [1]. - Other notable stocks included Guangqi Technology, with a transaction value of 230 million yuan, and Huichuan Technology, with 129 million yuan [1]. Group 2: Stock Performance - China Western Electric saw a price increase of 0.78%, closing at 6.47 yuan, with a transaction price of 5.78 yuan, reflecting a discount of 10.66% [1]. - Huatai Medical's stock rose by 1.21%, closing at 309.53 yuan, with a transaction price of 248.20 yuan, showing a discount of 19.81% [1]. - Other stocks with significant price movements included Guangqi Technology (+3.21%), Huichuan Technology (+1.48%), and Tongcheng New Materials (+3.29%) [1].

Core Insights - On September 11, 2023, Elys conducted five block trades totaling 488,700 shares, with a transaction value of 51.13 million yuan, at a price of 104.63 yuan per share, reflecting a 9.00% discount compared to the closing price of the day [2] - Over the past three months, Elys has recorded a total of 67 block trades, amounting to 844 million yuan [2] - The closing price of Elys on the same day was 114.98 yuan, marking a 1.16% increase, with a turnover rate of 1.59% and a total trading volume of 808 million yuan [2] Trading Activity - The block trades on September 11 included: - 20.77 million shares traded for 21.73 million yuan, with a buyer from Huajin Securities and a seller from CITIC Securities [2] - 15.42 million shares traded for 16.13 million yuan, with an institutional buyer and a seller from CITIC Securities [2] - Additional trades included 6.18 million shares for 6.47 million yuan, 4.58 million shares for 4.79 million yuan, and 1.92 million shares for 200,890 yuan, all at the same price of 104.63 yuan [2] Market Dynamics - Elys experienced a net outflow of 87.10 million yuan in principal funds throughout the day, with a cumulative increase of 3.12% over the past five days, despite a total net outflow of 126 million yuan during that period [2] - The latest margin financing balance for Elys stands at 928 million yuan, reflecting an increase of 34.43 million yuan, or 3.85%, over the past five days [2]

Summary of Key Points Core Viewpoint - On September 11, 18 stocks from the STAR Market experienced block trading, with a total transaction amount of 926 million yuan, indicating active trading in the sector [2]. Trading Overview - A total of 37 block trades were executed, with a cumulative trading volume of 13.07 million shares [2]. - The stock with the highest transaction amount was Huatai Medical, with a trading volume of 2.16 million shares and a transaction amount of 537 million yuan [2]. - Other notable transactions included Dameng Data and Yifang Bio, with transaction amounts of 83.43 million yuan and 62.41 million yuan, respectively [2]. Price Discount Analysis - Among the stocks involved in block trading, the highest discount rates relative to the closing prices were observed in Hengxuan Technology, Yuntian Lifi, and Huatai Medical, with discount rates of 25.15%, 23.13%, and 19.81% respectively [2]. Stock Performance - The STAR 50 Index rose by 5.32% on the same day, with 524 stocks (89.12%) in the STAR Market experiencing price increases [2]. - The average increase for stocks involved in block trading was 3.72%, with Dameng Data, Cambrian, and Hengxuan Technology leading the gains at 9.19%, 8.96%, and 6.88% respectively [2]. - Conversely, Junshi Biosciences and Aters saw declines of 1.59% and 0.24% respectively [2]. Institutional Participation - Out of the block trades, 12 transactions involved institutional buyers or sellers, covering 9 stocks [3]. - The top three stocks by institutional buying amounts were Dameng Data (83.43 million yuan), Yifang Bio (60.30 million yuan), and Aters (50.81 million yuan) [3]. Fund Flow Analysis - Among the stocks involved in block trading, 9 stocks saw net inflows from major funds, with the highest net inflows recorded for Yuntian Lifi (207 million yuan), Cambrian (184 million yuan), and Dameng Data (105 million yuan) [3]. - The stocks with the highest net outflows included Junshi Biosciences (99.41 million yuan), Aters (87.10 million yuan), and Borui Pharmaceutical (56.94 million yuan) [3].

Group 1 - On September 11, a block trade of 488,700 shares of Ailis was executed, with a transaction amount of 51.1327 million yuan, accounting for 5.95% of the total transaction volume for the day [1] - The transaction price was 104.63 yuan, which represents a 9% discount compared to the market closing price of 114.98 yuan [1]